Technetium Tc-99M Polyphosphate Kit

CHEMBL1201525 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

Technetium Tc-99m polyphosphate kit is a preparation of radiolabeled polyphosphate complexes used for bone scintigraphy and cardiac imaging, functioning similarly to other phosphate-based bone agents by adsorbing to hydroxyapatite in metabolically active osseous lesions. It represents an early bone imaging agent that preceded methylene diphosphonate preparations. The kit formulation allows on-site radiolabeling of the polyphosphate ligand with generator-produced technetium-99m.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

Technetium Tc-99m polyphosphate kit is a preparation of radiolabeled polyphosphate complexes used for bone scintigraphy and cardiac imaging, functioning similarly to other phosphate-based bone agents by adsorbing to hydroxyapatite in metabolically active osseous lesions. It represents an early bone imaging agent that preceded methylene diphosphonate preparations. The kit formulation allows on-site radiolabeling of the polyphosphate ligand with generator-produced technetium-99m.

Yes, Technetium Tc-99M Polyphosphate Kit is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201525. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.